Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE112164 | GEO | 2019/03/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (ChIP-seq data set)

Project description:To determine the binding of H3K4me1 and H3K4me3 to PCAT19 locus, we performed ChIP-seq in 22Rv1 cells.

2019-03-11 | GSE112120 | GEO

Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets)

Project description:To determine the functional mechanisms of PCAT19-long isoform and HNRNPAB, we conducted siRNA knockdown RNA-sequencing in prostate cancer cell line V16A.

2019-03-11 | GSE106774 | GEO

Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19

Project description:Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19

| PRJNA442593 | ENA

Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets)

Project description:Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets)

| PRJNA417969 | ENA

Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (ChIP-seq data set)

Project description:Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (ChIP-seq data set)

| PRJNA439377 | ENA

Super-Enhancer LncRNA LINC00162 Promotes Progression of Bladder Cancer.

Project description: Not available

| S-EPMC7736918 | biostudies-literature

Risk SNP-mediated enhancer-promoter interaction drives keloid through lncRNA DEIK

Project description:Genetics is a major factor for keloid predisposition and the genome-wide association study (GWAS) has identified a single nucleotide polymorphism (SNP) rs873549 at 1q41 as a susceptibility locus. However, the functional significance of this locus in keloid pathogenesis remains elusive. Here, we found that rs1348270, an enhancer located SNP in strong linkage disequilibrium with rs873549, mediated looping with the promoter of a lncRNA DEIK (Down Expressed In Keloids, formerly RP11-400N13.1). The risk variant was associated with decreased enhancer-promoter interaction and DEIK expression. Mechanistically, downregulation of DEIK increased the expression of collagens and chondrocyte and osteocyte associated genes such as POSTN and COMP through upregulating BMP2. Furthermore, correlation analysis revealed that DEIK expression was inversely correlated with BMP2, POSTN and COMP expression in keloid and normal fibroblasts. These findings uncover new mechanisms underlying genetic factor-mediated keloid predisposition and identify potential targets for keloid therapies.

2022-05-08 | GSE202293 | GEO

The association of lncRNA SNPs and SNPs-environment interactions based on GWAS with HBV-related HCC risk and progression.

Project description: Not available

| S-EPMC8077159 | biostudies-literature

LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p.

Project description: Not available

| S-EPMC6357332 | biostudies-literature

Risk SNP-mediated enhancer-promoter interaction drives keloid through lncRNA DEIK

Project description:Risk SNP-mediated enhancer-promoter interaction drives keloid through lncRNA DEIK

| PRJNA835406 | ENA